Risk factors associated with coronary artery calcification in midlife women: a population-based study

Oppermann, Karen; Colpani, Verônica; Spritzer, Poli Mara

doi:10.1080/09513590.2019.1604656

Cited by 3 publications

(4 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Contrary, observational studies showed the beneficial cardioprotective effect that can be obtained even with the use of low doses of oral HT (effect of 0.3 mg/day of oral conjugated equine estrogen was similar compere to a standard dose of 0.625 mg/day). The use of HT may delay the progression of the thickness of the intima-media layer of the carotid arteries, which in turn leads to atherosclerosis and coronary calcification [14,15]. However, the clinical trials confirming the cardioprotective benefits of HT in primary prevention have not been acknowledged yet.…”

Section: Hormone Therapymentioning

confidence: 99%

Menopause and women’s cardiovascular health: is it really an obvious relationship?

et al. 2022

View full text Add to dashboard Cite

Cardiovascular diseases are common for women and men but there are differences between the sexes in terms of clinical symptoms, pathophysiology and response to the treatment. CVD in women is commonly underdiagnosed and often women tend to have a lower perception of the risk. That can lead to delayed diagnosis and failed recognition of symptoms. Women develop heart disease later than men because of the protection that exists in the reproductive phase of their life. Once they enter menopause the risk increases. Estrogen provides a protective effect against heart disease in women. Therefore, the risk of CVD increases after menopause in most cases. Presented work emphasizes the importance of the menopausal period as the time of increasing CVD risk. Emphasize the importance of monitoring the health of women in their middle age, a critical time in which early intervention strategies should be implemented to reduce the risk of CVD.

show abstract

Section: Hormone Therapymentioning

confidence: 99%

Menopause and women’s cardiovascular health: is it really an obvious relationship?

et al. 2022

View full text Add to dashboard Cite

show abstract

“…been associated with protective effect against coronary artery calcification [71] and slower progression of carotid artery intima-media thickness, both of which are markers of subclinical CVD [72].…”

Section: Cardiovascular Riskmentioning

confidence: 99%

“…While CVD risk increases with menopause, this is difficult to distinguish from the effect of ageing [ 70 ]. Nonetheless, the use of menopausal hormone therapy (MHT) has been associated with protective effect against coronary artery calcification [ 71 ] and slower progression of carotid artery intima-media thickness, both of which are markers of subclinical CVD [ 72 ].…”

Section: Dietary Intake and Clinical Endpoints In Menopausal Womenmentioning

confidence: 99%

Nutrition in Menopausal Women: A Narrative Review

et al. 2021

Self Cite

View full text Add to dashboard Cite

Among the various aspects of health promotion and lifestyle adaptation to the postmenopausal period, nutritional habits are essential because they concern all women, can be modified, and impact both longevity and quality of life. In this narrative review, we discuss the current evidence on the association between dietary patterns and clinical endpoints in postmenopausal women, such as body composition, bone mass, and risk markers for cardiovascular disease. Current evidence suggests that low-fat, plant-based diets are associated with beneficial effects on body composition, but further studies are needed to confirm these results in postmenopausal women. The Mediterranean diet pattern along with other healthy habits may help the primary prevention of bone, metabolic, and cardiovascular diseases in the postmenopausal period. It consists on the use of healthy foods that have anti-inflammatory and antioxidant properties, and is associated with a small but significant decrease in blood pressure, reduction of fat mass, and improvement in cholesterol levels. These effects remain to be evaluated over a longer period of time, with the assessment of hard outcomes such as bone fractures, diabetes, and coronary ischemia.

show abstract

“…The transdermal estrogen patch at a dose of <50 ∞g/day in combination with micronized progesterone seems to be an innocuous choice. [ 3 4 ]…”

mentioning

confidence: 99%

Cardiovacular Diseases MHT and Midlife Health

Pradeep,

Anand

2023

Journal of Mid-Life Health

View full text Add to dashboard Cite

Risk factors associated with coronary artery calcification in midlife women: a population-based study

Cited by 3 publications

References 29 publications

Menopause and women’s cardiovascular health: is it really an obvious relationship?

Menopause and women’s cardiovascular health: is it really an obvious relationship?

Nutrition in Menopausal Women: A Narrative Review

Cardiovacular Diseases MHT and Midlife Health

Contact Info

Product

Resources

About